🔎 Trials Near Me

Akèy › Neoplazmi myeloproliferatif

Etid klinik pou Neoplazmi myeloproliferatif ap rekrite nan Etazini

50 etid pou Neoplazmi myeloproliferatif ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06661915

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT05320198

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07469891

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04996875

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT03471260

Cord Blood Transplant in Adults With Blood Cancers

Ap rekriteFaz 2
Laj 21 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT05884333

Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation

Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT06291987

CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT04493164

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

Ap rekrite
Laj 19 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04898790

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07008118

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT07249840

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07441694

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT06480591

Asciminib Roll-over Study

Ap rekriteFaz 4
Laj 7 a 100 · Tout sèks · Mizajou Jul 6, 2026 · NCT04877522

Allo HSCT Using RIC and PTCy for Hematological Diseases

Ap rekriteFaz 2
Jiska laj 75 · Tout sèks · Mizajou Jul 6, 2026 · NCT05805605

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.